Wegovy Before and After: What the Trial Data Actually Shows

Summary: In the STEP-1 trial, people on 2.4 mg semaglutide lost about 5% of body weight by week 12, 10% by week 28, and 14.9% by week 68. Most of the visible transformation happens between months three and twelve, and the regain after stopping is just as predictable.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The honest before and after for Wegovy looks like this: at the full 2.4 mg weekly dose, the average person in the STEP-1 trial lost 5% of starting body weight by week 12, 10% by week 28, and 14.9% by week 68 ^[1]. That is the headline number behind every transformation photo you have seen. A 250-pound starting weight becomes roughly 213 pounds at one year. A 180-pound starting weight becomes roughly 153 pounds. Bigger losses exist in the data, but they sit at the top end of the distribution and they almost always involve someone who trained, ate to a deficit, and stayed on the drug past week 68.

This page walks through the actual STEP-1 trajectory week by week, what physically changes on your body (waist, face, energy), what does not change (your need to move and eat well), and the part most coverage skips: the weight regain that happens when people stop.

The STEP-1 trajectory, the real timeline

STEP-1 was the 68-week randomized trial that the FDA used to approve Wegovy for chronic weight management ^[1]. It enrolled 1,961 adults with a BMI of 30 or higher (or 27 with a weight-related comorbidity), all without type 2 diabetes. Everyone got lifestyle counseling and a 500-calorie daily deficit prescription. Half got 2.4 mg semaglutide weekly. Half got placebo.

The published timeline of mean body weight change in the semaglutide arm:

Two things to notice. First, the curve is steepest between weeks 16 and 40. That is the window where the dose has reached therapeutic strength and the body has not yet adapted metabolically. Second, the curve flattens after week 52. That is the plateau most people hit in real life. Average loss does keep creeping up after that, but slowly, and individual variation widens.

About a third of people in STEP-1 lost 20% or more of their body weight. Another third lost between 10% and 20%. The remaining third lost less than 10%, and a small minority lost essentially nothing. The before-and-after photos that go viral on social media are sampled from the top responder bucket. They are real. They are not the average.

The first month: not much happens on the scale

The first month on Wegovy is the adjustment phase, not the fat-loss phase. You start at 0.25 mg, a deliberately sub-therapeutic dose designed to get your gut used to slowed gastric emptying without triggering the worst nausea ^[3]. Most people lose 1 to 2% of body weight in this window. A 200-pound person loses 2 to 4 pounds. That is normal. It is also not what the drug is built to do at this dose.

What you should notice in the first week of Wegovy: the food noise quiets down. The constant background mental chatter about what to eat next, when to snack, whether you are hungry, gets softer. By week 2, portion sizes shrink without conscious effort. By week 3, many people report leaving food on the plate for the first time in years. By week 4, you titrate up to 0.5 mg and the cycle repeats with stronger appetite suppression.

The titration ladder is 0.25 mg for four weeks, 0.5 mg for four weeks, 1.0 mg for four weeks, 1.7 mg for four weeks, then 2.4 mg as the maintenance dose ^[3]. If you hit week 20 at the full dose with no major issues, you are through the hardest part. Your fastest weight loss window starts now.

What physically changes between week 12 and week 52

The most visible transformations on Wegovy happen between roughly the three-month and twelve-month mark. The pattern is consistent across the trial data and the real-world reports:

Waist circumference. STEP-1 measured waist as a secondary endpoint. The semaglutide group lost an average of 13.5 cm of waist circumference at week 68, compared to 4.1 cm in the placebo group ^[1]. That is about 5.3 inches off the waist. Most of it comes from visceral fat, the metabolically active fat that wraps around your organs and drives insulin resistance. Visceral fat is also the fat that responds fastest to a caloric deficit, which is part of why the waist usually changes before the rest of the body catches up.

Face. "Ozempic face" and "Wegovy face" are not myths, they are facial fat loss combined with skin laxity. The fat pads in the cheeks and around the eyes shrink, the jawline becomes more defined, and people who were carrying weight in the face for years can look noticeably different by month four or five. In some cases that change is welcome. In others, especially in people over fifty or those who lose weight very fast, it reads as gaunt. The cosmetic upside and the cosmetic downside are the same physical process.

Energy. Energy levels typically dip in months one and two as your body adjusts to lower food intake and the GI side effects peak. By month three, most people report stable to improved energy. By month six, energy is usually meaningfully better than baseline, driven by better insulin sensitivity, better sleep, and the simple mechanics of carrying less weight around all day. The exception is people who undereat protein or skip meals because they are not hungry. That group ends up fatigued, weak, and at higher risk of muscle loss.

Other physical changes worth flagging. Many people report shoe size dropping by half a size as foot fat decreases. Ring size drops. Blood pressure usually falls within the first three months. Resting heart rate often comes down. Sleep apnea improves for many people by month six. These are not cosmetic, they are markers of the underlying metabolic shift the drug is producing.

What does not change

Wegovy does not eliminate the need for exercise. It does not eliminate the need to eat reasonably. It does not rewrite your relationship with food on its own.

The drug creates a window in which eating less is easier than it has ever been. The work you do inside that window decides whether the weight loss is durable and whether your body composition at the end of it is something you actually want.

Two specific gaps the drug does not fill:

Muscle. Roughly 25 to 40% of weight lost on GLP-1 drugs comes from lean mass when no resistance training is added. If you are losing 30 pounds, that is potentially 7 to 12 pounds of muscle, much of it skeletal muscle that supports your metabolism, posture, and strength into older age. Resistance training two to three times per week and protein intake at 1.2 to 1.6 grams per kilogram of body weight cuts that lean mass loss substantially. The trials that look best for body composition on semaglutide all include either supervised exercise or strong nutrition coaching.

Habits. Wegovy suppresses appetite. It does not teach you what to eat when you do eat. People who use the appetite suppression window to build sustainable food habits, regular protein-forward meals, less ultra-processed food, more fiber, keep their results when they eventually come off. People who eat the same diet as before, just less of it, often regain when the appetite returns.

Realistic transformation expectations vs social media

Social media before and after photos run on selection bias. The accounts that get followers are the top 5% of responders, often the people who started with the most weight to lose, often combined with intense exercise programs the drug did not provide. The 150-pound loss stories are real, they are not the median outcome.

For a more honest expectation:

A 33-pound loss on a 220-pound starting frame is a real transformation. Clothes fit differently. Blood markers improve. Energy returns. It is not the 100-pound transformation from the viral TikTok. It is what the drug actually does for the average person at the highest approved dose, with lifestyle support, over more than a year.

The people in the trial who beat the average tended to share a few features: higher baseline weight (more to lose), strong adherence to the dose titration, willingness to add resistance training and protein, and time on drug beyond 68 weeks. None of those are unique to Wegovy. They are the same factors that drive better outcomes with every weight loss intervention.

How fast is "fast" on Wegovy

The average rate of weight loss on Wegovy at full dose works out to roughly 0.5 to 1.0% of body weight per week during the steep middle phase, then slows. For a 220-pound person, that is about 1 to 2 pounds per week from roughly week 16 to week 40, then slower. Faster than that for sustained periods usually means you are also running a large additional caloric deficit, which carries muscle loss risk.

Plateaus happen. They are not failure. The STEP-1 curve itself has a slope change after week 52 because the body has reduced its energy expenditure to match the lower intake ^[1]. Pushing through a plateau usually means tightening the protein and resistance training, not adding more cardio or cutting more calories. People who try to force weight loss past a plateau by extreme restriction often quit the drug entirely within a few months.

The regression after stopping

This is the part of the before and after that most coverage leaves out. Wegovy is a chronic medication, not a course of treatment.

The STEP-1 extension trial followed participants for one year after stopping semaglutide. By 52 weeks off the drug, participants had regained an average of two thirds of the weight they had lost ^[4]. Cardiometabolic improvements, blood pressure, lipids, A1c, also largely reverted. The trial labeled this finding clearly: appetite returns when GLP-1 receptor stimulation stops, and most people return toward their pre-treatment weight in the absence of continued treatment.

STEP-4 looked at the inverse question. Participants ran a 20-week titration to full dose, hit an average 10.6% weight loss, then were randomized either to continue semaglutide or switch to placebo for the next 48 weeks ^[2]. The continued-semaglutide group lost another 7.9% on average. The placebo group regained 6.9%. The gap between staying on and stopping at the same starting point was nearly 15 percentage points of body weight over less than a year.

The honest implication: if you take Wegovy, lose 30 pounds, and then stop because you reached your goal weight, you should expect to regain roughly 20 of those pounds within a year unless you have aggressively rebuilt your habits to compensate for the lost appetite suppression. Some people do that successfully. Many do not. Going in expecting Wegovy to be a one-year program that resets your weight forever is a setup for disappointment.

What a realistic 12-month before and after looks like

If you start Wegovy today, follow the titration, reach 2.4 mg by week 20, take it consistently through week 52, and add modest lifestyle changes:

• Expect a 13 to 15% drop in body weight at one year.
• Expect roughly 5 inches off your waist.
• Expect noticeably different facial structure.
• Expect blood pressure and resting heart rate to fall.
• Expect more energy at month six than at month one.
• Expect to look like someone the same height who weighs 15% less, because that is what you will be.

You will not look like an underwear model unless you started looking close to that already. You will not lose 50% of your body weight. You will lose roughly what the STEP-1 trial averaged, plus or minus depending on adherence, lifestyle, and biology.

Common questions

How fast does Wegovy work for weight loss?

Appetite changes within 1 to 4 weeks. Visible weight loss starts around week 8 to 12. Full therapeutic effect arrives once you reach 2.4 mg at week 17 to 20. Most weight is lost between week 16 and week 52.

How much weight can you lose on Wegovy?

Average loss in STEP-1 was 14.9% of body weight at week 68 on the 2.4 mg dose. About one third of people lose 20% or more. About one third lose 10 to 20%. The rest lose less than 10%.

What is the average weight loss per week on Wegovy?

Roughly 0.5 to 1.0% of body weight per week during the steep mid-phase (weeks 16 to 40 at full dose). For a 220-pound person that is about 1 to 2 pounds per week. The rate slows after month nine.

What are typical Wegovy first month results?

Most people lose 1 to 2% of body weight in month one, which is 2 to 4 pounds for a 200-pound starting weight. The bigger first-month change is appetite, not the scale.

When do you start losing weight on Wegovy?

Slight weight loss begins in week 1 or 2 from reduced appetite. Visible, sustained weight loss usually begins between weeks 8 and 12, once the dose climbs above 0.5 mg.

What should I expect in the first week of Wegovy?

Reduced appetite within a few days, smaller portions without effort, possibly mild nausea or fatigue. Weight on the scale may not move much. The first week is the priming phase, not the fat-loss phase.

What happens at week 3 of Wegovy?

You are still on the starting dose of 0.25 mg. Appetite suppression is established for most people. Side effects often peak around now then ease. Weight loss is still modest, usually 1 to 2 pounds total.

Will I gain weight back if I stop Wegovy?

Yes for most people. The STEP-1 extension showed an average regain of about two thirds of lost weight within one year of stopping. STEP-4 showed continued loss when treatment continued and regain when it stopped, with a gap of nearly 15 percentage points after 48 weeks.

Do I still need to exercise on Wegovy?

Yes. The drug does not preserve muscle by itself. Without resistance training, 25 to 40% of weight lost can come from lean mass. Two to three sessions per week of strength training and 1.2 to 1.6 g/kg of protein materially improve body composition outcomes.

Is Wegovy weight loss visible on your face first?

Often yes. Facial fat is metabolically active and tends to come off faster than fat in the thighs or hips. Most people see facial changes by month four or five.

What this page does not cover

This is the realistic expectations page for Wegovy weight loss. Detailed dosing math, side effect management, what to do when you stop, and comparisons with tirzepatide and other GLP-1s each have their own dedicated articles on this site. Use the navigation to find them. The numbers here are from the STEP-1 and STEP-4 trials, which remain the strongest evidence base for what Wegovy actually does to body weight over a year and beyond.